{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:31Z","timestamp":1792083631003,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.065","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T15:19:13Z","timestamp":1687879153000},"page":"4941-4949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates"],"prefix":"10.1016","volume":"41","author":[{"given":"Yoshikazu","family":"Yuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4558-6917","authenticated-orcid":false,"given":"Norihiro","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-696X","authenticated-orcid":false,"given":"Shin-ichi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nakahashi-Ouchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yamanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Machita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1444-2630","authenticated-orcid":false,"given":"Masakatsu","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Akiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Fujihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"374","key":"10.1016\/j.vaccine.2023.06.065_b0005","first-page":"1561","article-title":"COVID-19 vaccine breakthrough infections","volume":"2021","author":"Gupta","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.06.065_b0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.065_b0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2023.06.065_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: From bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2023.06.065_b0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add9947","article-title":"Operation nasal vaccine\u2014Lightning speed to counter COVID-19","volume":"7","author":"Topol","year":"2022","journal-title":"Sci Immunol"},{"issue":"S4","key":"10.1016\/j.vaccine.2023.06.065_b0030","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.06.065_b0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/intimm\/dxab056","article-title":"Mucosal vaccines: wisdom from now and then","volume":"33","author":"Kiyono","year":"2021","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2023.06.065_b0040","first-page":"24","article-title":"Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2","author":"Park","year":"2021","journal-title":"IScience"},{"issue":"607","key":"10.1016\/j.vaccine.2023.06.065_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2023.06.065_b0050","doi-asserted-by":"crossref","unstructured":"Mao T, Israelow B, Suberi A, Zhou L, Reschke M, Pe\u00f1a-Hern\u00e1ndez MA, et al. Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses. BioRxiv 2022:2022.01.24.477597. 10.1101\/2022.01.24.477597.","DOI":"10.1101\/2022.01.24.477597"},{"key":"10.1016\/j.vaccine.2023.06.065_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2023.06.065_b0060","doi-asserted-by":"crossref","unstructured":"Yuki Y, Kiyono H. Mucosal vaccines: novel advances in technology and delivery. Http:\/\/DxDoiOrg\/101586\/Erv0961 2014;8:1083\u201397. 10.1586\/ERV.09.61.","DOI":"10.1586\/erv.09.61"},{"key":"10.1016\/j.vaccine.2023.06.065_b0065","doi-asserted-by":"crossref","unstructured":"Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, et al. Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell\u2019s Palsy in Switzerland. Https:\/\/DoiOrg\/101056\/NEJMoa030595 2004;350:896\u2013903. 10.1056\/NEJMOA030595.","DOI":"10.1056\/NEJMoa030595"},{"key":"10.1016\/j.vaccine.2023.06.065_b0070","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.06.065_b0075","first-page":"10","article-title":"Nasal administration of cholera toxin as a mucosal adjuvant damages the olfactory system in mice","author":"Fukuyama","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.065_b0080","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acs.molpharmaceut.0c01003","article-title":"Characterization and specification of a trivalent protein-based pneumococcal vaccine formulation using an adjuvant-free nanogel nasal delivery system","volume":"18","author":"Yuki","year":"2021","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.065_b0085","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.00240-13","article-title":"Nanogel-based pspa intranasal vaccine prevents invasive disease and nasal colonization by streptococcus pneumoniae","volume":"81","author":"Kong","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.06.065_b0090","first-page":"13","article-title":"Induction of mucosal IgA\u2013mediated protective immunity against nontypeable haemophilus influenzae infection by a cationic nanogel-based p6 nasal vaccine","author":"Nakahashi-Ouchida","year":"2022","journal-title":"Front Immunol"},{"issue":"25","key":"10.1016\/j.vaccine.2023.06.065_b0095","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2021.04.069","article-title":"A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci","volume":"39","author":"Nakahashi-Ouchida","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.065_b0100","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.4049\/jimmunol.1001789","article-title":"In vivo molecular imaging analysis of a nasal vaccine that induces protective immunity against botulism in nonhuman primates","volume":"185","author":"Yuki","year":"2010","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.065_b0105","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat Mater"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.065_b0110","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/mi.2015.5","article-title":"Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques","volume":"8","author":"Fukuyama","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2023.06.065_b0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jlcr.1758","article-title":"A facile automated synthesis of N-succinimidyl 4-[18F] fluorobenzoate ([18F]SFB) for18F-labeled cell-penetrating peptide as PET tracer","volume":"53","author":"Tang","year":"2010","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.vaccine.2023.06.065_b0120","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/acs.molpharmaceut.7b01000","article-title":"Panitumumab modified with metal-chelating polymers (MCP) complexed to 111 In and 177 Lu - An EGFR-targeted theranostic for pancreatic cancer","volume":"15","author":"Aghevlian","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2023.06.065_b0125","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1021\/la011454s","article-title":"Hierarchical self-assembly of hydrophobically modified pullulan in water: Gelation by networks of nanoparticles","volume":"18","author":"Kuroda","year":"2002","journal-title":"Langmuir"},{"key":"10.1016\/j.vaccine.2023.06.065_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114236","article-title":"Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics","volume":"184","author":"Vervaeke","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2023.06.065_b0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2014possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2023.06.065_b0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0969-8051(94)90174-0","article-title":"Metabolism of receptor targeted 111In-DTPA-glycoproteins: Identification of 111In-DTPA-\u220a-lysine as the primary metabolic and excretory product","volume":"21","author":"Franano","year":"1994","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.vaccine.2023.06.065_b0145","article-title":"Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo","volume":"55","author":"Rogers","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2023.06.065_b0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2967\/jnumed.106.037200","article-title":"Skeletal PET with 18F-fluoride: applying new technology to an old tracer","volume":"49","author":"Grant","year":"2008","journal-title":"J Nucl Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:45Z","timestamp":1759404525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23007545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23007545"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}